Susquehanna International Group, LLP Intra Cellular Therapies, Inc. Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	SELL	$64.76 - $79.84 $200,756 - $247,504	-3,100 Reduced 2.13%	142,700 $9.77 Million
Q1 2024 May 07, 2024	BUY	$64.37 - $75.65 $4.47 Million - $5.25 Million	69,400 Added 90.84%	145,800 $10.1 Million
Q4 2023 Feb 14, 2024	BUY	$46.37 - $73.65 $2.36 Million - $3.76 Million	51,000 Added 200.79%	76,400 $5.47 Million
Q3 2023 Nov 14, 2023	SELL	$52.09 - $64.1 $1.71 Million - $2.11 Million	-32,900 Reduced 56.43%	25,400 $1.32 Million
Q2 2023 Aug 11, 2023	SELL	$54.67 - $66.44 $360,822 - $438,504	-6,600 Reduced 10.17%	58,300 $3.69 Million
Q1 2023 May 16, 2023	SELL	$43.8 - $56.99 $302,220 - $393,231	-6,900 Reduced 9.61%	64,900 $3.51 Million
Q4 2022 Feb 14, 2023	SELL	$44.07 - $54.45 $193,908 - $239,580	-4,400 Reduced 5.77%	71,800 $3.8 Million
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $713,090 - $1 Million	16,700 Added 28.07%	76,200 $3.55 Million

400

87.2M

309K

302K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $6.86B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.